Obesity drugs pose a big challenge for health care equity

Taking stock of the drug industry, from the lab to the medicine chest

June 7, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Scott Olson/Getty Images Opinion: Obesity drugs pose a big challenge for health care equity The high cost and limited availability of new obesity medicines put them out of reach of most global citizens. By Jayasree K. Iyer STAT+ | FDA reviewers ask if approval of Lilly's Alzheimer's drug should be restricted to a smaller group The questions asked by reviewers, included in briefing documents posted Thursday, reveal why the agency decided to hold an advisory panel for the medicine. By Matthew Herper and Elaine Chen STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser